المؤلفون: Isaac Sinay, Felipe Martinez, Daniel Einhorn, Alberto S. Villamil, Antonio Roberto Chacra, Naomi S. Levitt, Markku Laakso, Mitradev Boolell, Brendan M. Buckley, Viacheslav Mareev, Chantal Masson, Gianni Tognoni, Chang-yu Pan, Gregory R. Fulcher, Prakash Deedwania, Yuri N. Belenkov, Fu-Tien Chiang, Tsushung A. Hua, Thomas D. Giles, Edward S. Horton, Steven M. Haffner, Hasan Ilkova, John B. Buse, Melanie J. Davies, Sotirios A. Raptis, Sonia Gaztambide, Björn Holzhauer, Vivian Fonseca, André Scheen, Peter Diem, Gyula Tamás, Ole Schmitz, R. Prager, Richard W. Nesto, Rury R. Holman, J. Tuomilehto, Bernard Charbonnel, Lawrence A. Leiter, Herbert Sandstroem, John J.V. McMurray, Eduardo Meaney, Frank Schaper, Juraj Vozar, Robert M. Califf, Theodore Mazzone, Guy E.H.M. Rutten, Zbigniew Gaciong, Trond Jenssen, Steen Stender, Vladimír Soška, Henry Krum, M. Angelyn Bethel, Steven E. Kahn, Chun Chung Chow

المصدر: Holman, R R, Haffner, S M, McMurray, J J, Bethel, M A, Holzhauer, B, Hua, T A, Belenkov, Y, Boolell, M, Buse, J B, Buckley, B M, Chacra, A R, Chiang, F-T, Charbonnel, B, Chow, C-C, Davies, M J, Deedwania, P, Diem, P, Einhorn, D, Fonseca, V, Fulcher, G R, Gaciong, Z, Gaztambide, S, Giles, T, Horton, E, Ilkova, H, Jenssen, T, Kahn, S E, Krum, H, Laakso, M, Leiter, L A, Levitt, N S, Mareev, V, Martinez, F, Masson, C, Mazzone, T, Meaney, E, Nesto, R, Pan, C, Prager, R, Raptis, S A, Rutten, G E H M, Sandstroem, H, Schaper, F, Scheen, A, Schmitz, O, Sinay, I, Soska, V, Stender, S, Tamás, G, Tognoni, G & NAVIGATOR Study Group 2010, ' Effect of nateglinide on the incidence of diabetes and cardiovascular events ', The New England Journal of Medicine, vol. 362, no. 16, pp. 1463-76 . https://doi.org/10.1056/NEJMoa1001122

مصطلحات موضوعية: Blood Glucose, Male, Tetrazoles, Nateglinide, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Impaired glucose tolerance, 0302 clinical medicine, Risk Factors, Cumulative incidence, Treatment Failure, Incidence, Hazard ratio, Valine, General Medicine, Middle Aged, 3. Good health, Cardiovascular Diseases, Cardiology, Valsartan, Drug Therapy, Combination, Female, medicine.drug, medicine.medical_specialty, Phenylalanine, 030209 endocrinology & metabolism, Hypoglycemia, 03 medical and health sciences, Double-Blind Method, Cyclohexanes, Diabetes mellitus, Internal medicine, Glucose Intolerance, medicine, Humans, Hypoglycemic Agents, Exercise, Kaplan-Meiers Estimate, Proportional Hazards Models, business.industry, Proportional hazards model, Body Weight, medicine.disease, Confidence interval, Surgery, Diabetes Mellitus, Type 2, business, Angiotensin II Type 1 Receptor Blockers, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c543568a1dc744d44f9b818fe6f3ab
https://pubmed.ncbi.nlm.nih.gov/21109678

المؤلفون: Steen Stender, Isaac Sinay, Frank Schaper, Daniel Einhorn, Sotirios A. Raptis, Hasan Ilkova, Zbigniew Gaciong, Viacheslav Mareev, Brendan M. Buckley, John J.V. McMurray, Prakash Deedwania, Markku Laakso, Lawrence A. Leiter, M A Bethel, Guy E.H.M. Rutten, Edward S. Horton, Vladimír Soška, Antonio Roberto Chacra, Felipe Martinez, Steven E. Kahn, Trond Jenssen, Eduardo Meaney, Steven M. Haffner, Gregory R. Fulcher, Bernard Charbonnel, Vivian Fonseca, Bjoern Holzhauer, Yuri N. Belenkov, Juraj Vozar, Mitradev Boolell, Rury R. Holman, Herbert Sandstroem, Thomas D. Giles, Peter Diem, Robert M. Califf, Chun Chung Chow, Tsushung Hua, Fu-Tien Chiang, André Scheen, Naomi S. Levitt, John B. Buse, Melanie J. Davies, Sonia Gaztambide, Theodore Mazzone, R. Prager, Richard W. Nesto, Gyula Tamás, Ole Schmitz, Alberto S. Villamil, Chantal Masson, Gianni Tognoni, Chang-yu Pan, Jaakko Tuomilehto, Henry Krum

المصدر: McMurray, J J, Holman, R R, Haffner, S M, Bethel, M A, Holzhauer, B, Hua, T A, Belenkov, Y, Boolell, M, Buse, J B, Buckley, B M, Chacra, A R, Chiang, F-T, Charbonnel, B, Chow, C-C, Davies, M J, Deedwania, P, Diem, P, Einhorn, D, Fonseca, V, Fulcher, G R, Gaciong, Z, Gaztambide, S, Giles, T, Horton, E, Ilkova, H, Jenssen, T, Kahn, S E, Krum, H, Laakso, M, Leiter, L A, Levitt, N S, Mareev, V, Martinez, F, Masson, C, Mazzone, T, Meaney, E, Nesto, R, Pan, C, Prager, R, Raptis, S A, Rutten, G E H M, Sandstroem, H, Schaper, F, Scheen, A, Schmitz, O, Sinay, I, Soska, V, Stender, S, Tamás, G, Tognoni, G & NAVIGATOR Study Group 2010, ' Effect of valsartan on the incidence of diabetes and cardiovascular events ', The New England Journal of Medicine, vol. 362, no. 16, pp. 1477-90 . https://doi.org/10.1056/NEJMoa1001121

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, Phenylalanine, Tetrazoles, 030209 endocrinology & metabolism, Blood Pressure, Nateglinide, 030204 cardiovascular system & hematology, Impaired glucose tolerance, Coronary artery disease, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Cyclohexanes, Risk Factors, Diabetes mellitus, Internal medicine, Glucose Intolerance, medicine, Humans, Hypoglycemic Agents, Cumulative incidence, Exercise, Proportional Hazards Models, business.industry, Unstable angina, Incidence, Hazard ratio, Body Weight, Valine, General Medicine, Middle Aged, medicine.disease, 3. Good health, Surgery, Valsartan, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Cardiology, Drug Therapy, Combination, Female, Metabolic syndrome, business, Angiotensin II Type 1 Receptor Blockers, medicine.drug, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d21d05719d20cfa649dcf4b380ab264
https://pubmed.ncbi.nlm.nih.gov/21646316